COURTNEY JOHNSON: Open Payments
NPI 1699253336 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 53 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $180 |
| Novo Nordisk Inc | 11 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $137 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Astellas Pharma US Inc | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Globus Medical, Inc. | 1 | $28 |
| Organon LLC | 1 | $23 |
Products named: JARDIANCE, MOUNJARO, Ozempic, TRELEGY ELLIPTA, KISUNLA, TZIELD, Wegovy, Veozah.
Industry payments across TX — which companies pay providers there.
